Abiopharma

Clinical trial NCT02386800: primary completion date: 2027-09-16 → 2032-04-05.

Clinical trial NCT04033445: completion date: 2027-09-29 → 2027-07-16.

Clinical trial NCT07612267 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-06-01 → 2026-08-05

Clinical trial NCT05746247 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. primary completion date: 2026-01-31 → 2026-06-30 3. enrollment: 750 → 610 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06955169 updates: 1. enrollment: 4 → 130 participants 2. enrollment type: ACTUAL → ESTIMATED

Clinical trial NCT07631286: start date: 2026-06-01 → 2026-06-15.

Clinical trial NCT04572451 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-31 → 2027-08-05 3. primary completion date: 2024-05-17 → 2026-10-07

Clinical trial NCT06185764 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 52 → 47 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT03661307: status: SUSPENDED → RECRUITING.

Clinical trial NCT06494540 updates: 1. completion date: 2028-06-30 → 2029-12-31 2. primary completion date: 2028-06-30 → 2029-12-31

Clinical trial NCT07283705: start date: 2026-05-18 → 2026-04-09.

Clinical trial NCT07123090 updates: 1. completion date: 2028-02-01 → 2028-04-01 2. primary completion date: 2026-10-01 → 2027-10-01

Clinical trial NCT07712874: start date: 2026-08-24 → 2026-08-25.

Clinical trial NCT06505005 updates: 1. status: ENROLLING_BY_INVITATION → COMPLETED 2. completion date: 2026-05-01 → 2026-08-01 3. primary completion date: 2026-05-01 → 2026-08-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04933903 updates: 1. completion date: 2026-09-01 → 2026-12-01 2. primary completion date: 2026-06-01 → 2026-10-01